Telemedicine in the treatment of addictions
- PMID: 35674721
- DOI: 10.1097/YCO.0000000000000795
Telemedicine in the treatment of addictions
Abstract
Purpose of review: The purpose of this update is to provide an overview of recent research publications (January 2020-January 2022) on real-time telemedicine solutions for the management of addictions (alcohol, tobacco, opioids, and other drugs).
Recent findings: Motivational interviewing by real-time telemedicine showed effectiveness in youth and adults for risky alcohol use and alcohol use disorders, even when a concurrent mental health disorder exists. Live telemedicine is well accepted for managing tobacco use disorders. The range of interventions for treating opioid use disorder by real-time telemedicine is large and has been increased due to the coronavirus disease 2019 (COVID-19) pandemic (prescription of opioid agonists, peer-to-peer support, counseling, and group therapy).
Summary: The COVID-19 pandemic has accelerated the implementation of real-time telemedicine and, in parallel, research has been conducted to test its effectiveness. Videoconferencing and telephone interventions are supported by solid evidence for risky alcohol use and alcohol use disorder, tobacco use disorder and opioid use disorder. The Integration of other types of telemedicine (asynchronous telemedicine and remote monitoring) and with the entire health system is lacking. Many areas and vulnerable populations (e.g., homeless, elderly, and cannabis use disorders) need more attention.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Global Burden of Disease (GBD). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1345–1422.
-
- WHO | Global status report on alcohol and health 2018. WHO. 2019. Available at: http://www.who.int/substance_abuse/publications/global_alcohol_report/gs... [Accessed 15 October 2020].
-
- López-Pelayo H, Aubin HJ, Drummond C, et al. The post-COVID era: challenges in the treatment of substance use disorder (SUD) after the pandemic. BMC Med 2020; 18:1–8.
-
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). m-Health applications for responding to drug use and associated harms. Luxemburg:2018.
-
- Mechanic OJ, Persaud Y, Kimball AB. Telehealth systems. StatPearls. 2021. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459384/ [Accessed 4 March 2022].
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials